AQP4 and Brain atrophy: Reports on attack-related and chronic-progressive brain atrophy in AQP4-IgG-positive NMOSD exist, but data on the structured involved and the severity vary among studies [50, 63, 135, 209, 221]; currently, monitoring of brain atrophy is not generally recommended outside of clinical studies.